AU2001276702A1 - Method of evaluating antifungal agent - Google Patents

Method of evaluating antifungal agent

Info

Publication number
AU2001276702A1
AU2001276702A1 AU2001276702A AU7670201A AU2001276702A1 AU 2001276702 A1 AU2001276702 A1 AU 2001276702A1 AU 2001276702 A AU2001276702 A AU 2001276702A AU 7670201 A AU7670201 A AU 7670201A AU 2001276702 A1 AU2001276702 A1 AU 2001276702A1
Authority
AU
Australia
Prior art keywords
antifungal agent
phospholipid
microorganism
nonionic surfactant
biological tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276702A
Inventor
Takao Ito
Takuji Nakashima
Akira Nozawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pola Chemical Industries Inc
Original Assignee
Pola Chemical Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chemical Industries Inc filed Critical Pola Chemical Industries Inc
Publication of AU2001276702A1 publication Critical patent/AU2001276702A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/06—Quantitative determination
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A correct viable cell number of a microorganism in a biological tissue is measured by cultivating a fragment of the biological tissue such as skin infected with the microorganism and administered with an antimicrobial agent, in a medium containing a phospholipid, a nonionic surfactant, or both of the phospholipid and the nonionic surfactant. <IMAGE>
AU2001276702A 2000-08-01 2001-07-31 Method of evaluating antifungal agent Abandoned AU2001276702A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000232689 2000-08-01
JP2000-232689 2000-08-01
PCT/JP2001/006584 WO2002010440A1 (en) 2000-08-01 2001-07-31 Method of evaluating antifungal agent

Publications (1)

Publication Number Publication Date
AU2001276702A1 true AU2001276702A1 (en) 2002-02-13

Family

ID=18725332

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276702A Abandoned AU2001276702A1 (en) 2000-08-01 2001-07-31 Method of evaluating antifungal agent

Country Status (8)

Country Link
US (2) US6929927B2 (en)
EP (1) EP1306445B1 (en)
JP (1) JP3927117B2 (en)
AT (1) ATE449866T1 (en)
AU (1) AU2001276702A1 (en)
CA (1) CA2417648C (en)
DE (1) DE60140611D1 (en)
WO (1) WO2002010440A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3927117B2 (en) * 2000-08-01 2007-06-06 ポーラ化成工業株式会社 Antifungal evaluation method
KR20030082942A (en) * 2001-02-27 2003-10-23 스미스 앤드 네퓨, 인크. Total knee arthroplasty systems and processes
JP4824493B2 (en) * 2005-08-31 2011-11-30 株式会社ポーラファルマ Antifungal evaluation method
US8078440B2 (en) 2008-09-19 2011-12-13 Smith & Nephew, Inc. Operatively tuning implants for increased performance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201791B (en) 1991-03-19 1993-03-11 Becton Dickinson Co
JPH06189739A (en) 1992-04-15 1994-07-12 Hiroshi Oogase Stamping culture medium for testing methicillin-resistant staphylococcus aureus and method for testing methicillin-resistant staphylococcus aureus
DE4328689A1 (en) * 1993-08-26 1995-03-02 Beiersdorf Ag Method for detecting and counting microorganisms
JP3927117B2 (en) * 2000-08-01 2007-06-06 ポーラ化成工業株式会社 Antifungal evaluation method

Also Published As

Publication number Publication date
JPWO2002010440A1 (en) 2004-01-15
DE60140611D1 (en) 2010-01-07
WO2002010440A1 (en) 2002-02-07
US6929927B2 (en) 2005-08-16
US20050250174A1 (en) 2005-11-10
JP3927117B2 (en) 2007-06-06
EP1306445A1 (en) 2003-05-02
ATE449866T1 (en) 2009-12-15
US20040101866A1 (en) 2004-05-27
EP1306445A4 (en) 2005-04-13
CA2417648C (en) 2011-01-25
US7052866B2 (en) 2006-05-30
EP1306445B1 (en) 2009-11-25
CA2417648A1 (en) 2003-01-29

Similar Documents

Publication Publication Date Title
BR9913234A (en) Absorbent article with reduced viability of candida albicans
HK1040475A1 (en) Bactericidal/disinfectant peracetic acid composition
AU2001231900A1 (en) Cell and tissue culture device with improved culture fluid circulation
BR0312103A (en) Combinations of fungicidal active substances
EP0827410A4 (en) Method for introducing and expressing genes in animal cells
AU1264295A (en) Anatomical and biological preservative and improved embalming composition and method
DE60029107D1 (en) LUCIFERASE EXPRESSION CASSETTES AND METHODS OF USE THEREOF
AU2001276702A1 (en) Method of evaluating antifungal agent
AU2001232994A1 (en) Compositions treated to inactivate infectious proteins
AU2001258303A1 (en) Active substance combinations with insecticidal and acaricidal properties
MXPA03001447A (en) Water emulsifiable formulations.
TR199700796T1 (en) Controlling post-harvest fungal diseases with the use of saprophytic yeast.
WO2004022775A8 (en) Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use
ATE265143T1 (en) METHOD FOR FIGHTING MICROORGANISMS
AU7670498A (en) Disposable absorbent articles with improved skin dryness performance and wit h improved core and chassis backsheet breathabilities
ATE353642T1 (en) USE OF HYPOESTOXIDES AS ANTIPARASITIVE AGENTS
WO2003059262A3 (en) Method and composition for treating and preventing hiv infection and aids
WO2001089558A3 (en) Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
WO2004015141A3 (en) Method for the rapid assessment of the presence and viability of bacterial cells and use thereof________________________
ES2096592T3 (en) DISINFECTION PROCESS FOR MUSCULOSKELETAL TISSUE AND TISSUES SO PREPARED.
EP0932337A4 (en) Vitrification solutions for shelf preservation of cells, tissues, organs and organisms
ES2093182T3 (en) ANTIBIOTIC AB-041 AND PROCEDURE FOR ITS OBTAINING.
AU2000255261A1 (en) Means for maintenance and/or correction of glucose concentration in blood
PT1380208E (en) DISINFECTANT AGENT WITH ANTIPARASITIC ACTIVITY
ES2093054T3 (en) ANTIBIOTICS AB-023 AND PROCEDURE FOR ITS PREPARATION.